Answers are grounded in this paper and cite their sources.
Cellular immunotherapy is recognized as the fourth tumor treatment after surgery, radiotherapy and chemotherapy.Chimeric antigen receptor (CAR)-T-cell therapy belongs to adoptive cellular immunotherapy.CAR-T not only has made great breakthroughs in cancer treatment, but also has good application prospects in the treatment of infectious diseases and autoimmune diseases.This article reviews the development history, clinical applications, current problems and the latest research progress of CAR-T cell immunotherapy.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: